Results 71 to 80 of about 3,098 (190)

Relapsing Polychondritis that Recovers Rapidly with One-Dose Steroid: A Case Report

İstanbul Medical Journal, 2015
Relapsing polychondritis is a rare, autoimmune, multisystemic disease that presents with episodic inflammatory process of the cartilages. We report a case of a 48-year-old woman who presented to our otolaryngology clinic with complaints of pain, eritema,
Abdurrahman Bozkurttan, Süheyl Haytoğlu, Soner Kadıköylü, Umut Aslan, Osman Kürşat Arıkan   +4 more
doaj   +1 more source

Relapsing polychondritis and otologic findings [PDF]

, 2014
WOS: 000439915800008PubMed ID: 28058312Relapsing polychondritis is a cartilage tissue disease characterized by inflammatory and destructive episodes. Elastic cartilage of the ear and nose, hyaline cartilage of the joints, hyaline cartilage of vertebra ...
Oran, Abdulkadir, Demirkuru, Fatma, Derin, Serhan, Ucar, Selcuk   +3 more
core   +1 more source

Beyond an Inflamed Ear

Acta Médica Portuguesa, 2014
Keywords: Ear Diseases; Ear, External; Polychondritis, Relapsing.
Cristina Ponte, Carla Macieira
doaj   +1 more source

Relapsing Polychondritis [PDF]

Proceedings of the Royal Society of Medicine, 1971
R A, Hughes, N, Curry, M H, Lessof
openaire   +5 more sources

Doc, Just Cut My Ears Off—A Case Report of Actinomyces in Bilateral Chronic Auricular Chondritis

The Laryngoscope, Volume 135, Issue 10, Page 3651-3653, October 2025.
Ear piercings can lead to infectious complications, commonly involving Staphylococcus aureus and Pseudomonas aeruginosa . This is the first documented case of bilateral chronic auricular chondritis caused by Actinomyces odontolyticus following cartilage piercings.
Niketna Vivek, Austin Hoke, Priyesh N. Patel, Kenneth C. Fletcher   +3 more
wiley   +1 more source

Safety and Effectiveness of Combination Rituximab and Cyclophosphamide Therapy for Treating Pediatric Patients With Severe Manifestations of Rheumatic Disease

ACR Open Rheumatology, Volume 7, Issue 9, September 2025.
Objective Current practice guidelines recommend the use of either rituximab (RTX) or cyclophosphamide (CYC) for the treatment of severe manifestations of systemic vasculitis or connective tissue disease. Few studies have evaluated safety and efficacy outcomes of combination therapy with RTX and CYC.
Eileen Rife, Daniel Reiff, John Bridges, Randall Q. Cron, Emily Smitherman, Matthew L. Stoll, Livie Timmerman, Peter Weiser, Melissa L. Mannion   +8 more
wiley   +1 more source

Incidence and mortality of relapsing polychondritis in the UK:a population-based cohort study [PDF]

, 2015
OBJECTIVE: Relapsing polychondritis is a rare disease characterized by cartilage inflammation. Our aim was to estimate the incidence, prevalence and mortality of relapsing polychondritis and describe the clinical features of relapsing polychondritis in a
Charlton, Judith, Gulliford, Martin C, Dregan, Alex; id_orcid, D'Cruz, David P, Hazra, Nisha   +4 more
core   +2 more sources

Síndrome de Sweet e policondrite recidivante reveladores de síndrome mielodisplásica Sweet's Syndrome and relapsing polychondritis signal myelodysplastic syndrome

Anais Brasileiros de Dermatologia, 2011
Certas dermatoses, pertencentes ao grupo das síndromes paraneoplásicas mucocutâneas, podem ser o prenúncio de uma neoplasia previamente não conhecida. Tanto a síndrome de Sweet como a policondrite recidivante incluem-se neste grupo. A síndrome de Sweet e
Filipa da Encarnação Roque Diamantino, Pedro Manuel Oliveira da Cunha Raimundo, Ana Isabel Pina Clemente Fidalgo   +2 more
doaj   +1 more source

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

Rheumatology &Autoimmunity, Volume 6, Issue 1, Page 60-62, March 2026.
Lilian Vasaitis, Lena Blomstrand, Tatjana Pandzic, Miklos Gulyas, Panagiotis Baliakas, Viktor Ljungström   +5 more
wiley   +1 more source

Clinical Factors Associated With Pneumocystis Pneumonia Despite Its Primary Prophylaxis: When to Stop Prophylaxis?

Arthritis &Rheumatology, Volume 77, Issue 9, Page 1263-1272, September 2025.
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim, Se Rim Choi, Jin Kyun Park, Eun Young Lee, Eun Bong Lee, Jun Won Park   +5 more
wiley   +1 more source